Oyster Point Pharma reports third quarter 2022 financial results on…
PRINCETON, NJ, November 02, 2022 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. OYSTER a commercial-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class pharmaceutical